Clinical trial
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's…
NCT00006039 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006039 |
|---|---|
| Title | Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma |
| Official title | Phase II Study of Weekly Administered High-Dose Pegylated Interferon Alfa-2B (PEGIntron) in Advanced Stage Low Grade Non-Hodgkin's Lymphoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Small Intestine Cancer |
| Intervention type | Biological |
| Interventions | pegylated interferon alfa |
| Start date | Dec 1, 1999 |
| Primary completion | Mar 1, 2001 |
| Completion | Mar 1, 2001 |
| First posted | May 3, 2004 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: